We are live on ! Find out more
PWM

Palumbo Wealth Management Portfolio holdings

AUM $410M
1-Year Est. Return 32.56%
This Fund
S&P 500
This Quarter Est. Return
+13.08%
1 Year Est. Return
+32.56%
3 Year Est. Return
+80.66%
5 Year Est. Return
+99.66%
10 Year Est. Return
AUM
$313M
AUM Growth
-$9.8M
Cap. Flow
+$45M
Cap. Flow %
14.38%
Top 10 Hldgs %
40.97%
Holding
235
New
38
Increased
107
Reduced
31
Closed
56

Sector Composition

Rank Sector Weight
1 Technology 19.49%
2 Consumer Discretionary 11.97%
3 Healthcare 11.39%
4 Industrials 7.98%
5 Financials 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBS icon
101
Emergent Biosolutions
EBS
$389M
$425K 0.14%
+48,196
New +$375K
BLK icon
102
Blackrock
BLK
$176B
$423K 0.14%
4,168
+3,747
+890% +$4.19M
NFLX icon
103
Netflix
NFLX
$309B
$420K 0.13%
4,900
+430
+10% +$52.5K
QS icon
104
QuantumScape Corp
QS
$3.4B
$417K 0.13%
33,855
+1,855
+6% +$18.1K
PHVS icon
105
Pharvaris
PHVS
$2.34B
$415K 0.13%
16,641
+2,092
+14% +$46.4K
GTLB icon
106
GitLab
GTLB
$6.11B
$414K 0.13%
9,184
+1,228
+15% +$56.2K
XGN icon
107
Exagen
XGN
$161M
$414K 0.13%
37,627
-28,385
-43% -$251K
LIN icon
108
Linde
LIN
$226B
$412K 0.13%
1,021
+24
+2% +$11.4K
LXEO icon
109
Lexeo Therapeutics
LXEO
$349M
$407K 0.13%
61,276
+4,973
+9% +$24.1K
PAYX icon
110
Paychex
PAYX
$42.1B
$403K 0.13%
3,178
-32
-1% -$4.44K
SANA icon
111
Sana Biotechnology
SANA
$977M
$395K 0.13%
111,288
+30,195
+37% +$109K
DSGN icon
112
Design Therapeutics
DSGN
$849M
$392K 0.13%
52,081
-8,474
-14% -$42.4K
DFTX
113
Definium Therapeutics
DFTX
$5.89B
$388K 0.12%
32,929
+8,886
+37% +$82.9K
SO icon
114
Southern Company
SO
$107B
$379K 0.12%
4,536
+246
+6% +$23K
AMGN icon
115
Amgen
AMGN
$220B
$377K 0.12%
1,389
-51
-4% -$14.8K
PKG icon
116
Packaging Corp of America
PKG
$22.8B
$373K 0.12%
1,717
+6
+0.4% +$1.24K
PRU icon
117
Prudential Financial
PRU
$41.7B
$365K 0.12%
3,648
+173
+5% +$18.2K
RTX icon
118
RTX Corp
RTX
$300B
$355K 0.11%
2,511
+64
+3% +$9.93K
PTGX icon
119
Protagonist Therapeutics
PTGX
$8.83B
$350K 0.11%
5,268
-2,262
-30% -$129K
IMRX icon
120
Immuneering
IMRX
$284M
$343K 0.11%
+49,052
New +$255K
GM icon
121
General Motors
GM
$78.2B
$340K 0.11%
5,878
+311
+6% +$17.3K
XFOR icon
122
X4 Pharmaceuticals
XFOR
$391M
$326K 0.1%
+95,327
New +$246K
ESTC icon
123
Elastic
ESTC
$7.25B
$323K 0.1%
3,824
+428
+13% +$36K
GFL icon
124
GFL Environmental
GFL
$14.9B
$321K 0.1%
6,765
-4,218
-38% -$204K
ROKU icon
125
Roku
ROKU
$21.8B
$321K 0.1%
3,202
+282
+10% +$26K

Similar funds

Palumbo Wealth Management's Q3 2025 Portfolio in Review

As of Q3 2025, Palumbo Wealth Management held 235 positions worth $313M, down 3% from $323M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Palumbo Wealth Management deployed $45M of net new capital in Q3 2025, opening 38 new positions and adding to 107 existing holdings. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 416,315 shares worth $51.9K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was SPDR Gold Trust, an estimated $2.86M trimmed.

  • Palumbo Wealth Management's largest Q3 2025 buy was JPMorgan BetaBuilders International Equity ETF: 416,315 shares worth $51.9K.
  • Palumbo Wealth Management added most to iShares 1-3 Year Treasury Bond ETF in Q3 2025, an estimated $8.39M increase.
  • Palumbo Wealth Management's biggest Q3 2025 reduction was SPDR Gold Trust, cutting an estimated $2.86M.
  • Palumbo Wealth Management fully exited JPMorgan Ultra-Short Income ETF in Q3 2025, selling an estimated $19.7M.
  • Palumbo Wealth Management's ten largest holdings make up 41% of its $313M portfolio in Q3 2025.
  • Palumbo Wealth Management opened 38 new positions and closed 56 in Q3 2025.
  • Palumbo Wealth Management's portfolio value fell 3% quarter-over-quarter to $313M.

Based on Palumbo Wealth Management's 13F filing for Q3 2025, filed 10 Nov 2025.